CREDIT AGREEMENT AND GUARANTYCredit Agreement • May 16th, 2022 • Impel Pharmaceuticals Inc • Pharmaceutical preparations • New York
REVENUE INTEREST FINANCING AGREEMENTSecurity Agreement • May 16th, 2022 • Impel Pharmaceuticals Inc • Pharmaceutical preparations • New York
This REVENUE INTEREST FINANCING AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of March 17, 2022, by and between Impel NeuroPharma, Inc., a Delaware corporation (the “Company”), and the entities listed in Schedule 1 hereto (the “Purchasers”), and Oaktree Fund Administration, LLC, as administrative agent for the Purchasers (in such capacity, the “Administrative Agent” and, together with the Company and the Purchasers, the “Parties”, and each a “Party”).
